CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Research context
CSPC Innovation Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
CSPC Innovation Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 7.8% below its 200 day moving average.
From a valuation standpoint, the stock is 16.1% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 5.7.
CSPC Innovation Pharmaceutical Co., Ltd's total revenue sank by 4.0% to $285M since the same quarter in the previous year.
Its net income has dropped by 28.8% to $43M since the same quarter in the previous year.
Finally, its free cash flow fell by 22.5% to $50M since the same quarter in the previous year.
Based on the above factors, CSPC Innovation Pharmaceutical Co., Ltd gets an overall score of 1/5.